Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 55-62

Spandidos Publications

Access to resources Recommend Favorite

Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer

By Brunsvig Paal   Aamdal Steinar   Gjertsen Marianne   Kvalheim Gunnar   Markowski-Grimsrud Carrie   Sve Ingunn   Dyrhaug Marianne   Trachsel Sissel   Møller Mona   Eriksen Jon   Gaudernack Gustav  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1553-1564

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer

By Hirose Takashi   Shirai Takao   Ishida Hiroo   Ando Kohichi   Sugiyama Tomohide   Kusumoto Sojiro   Hosaka Takamichi   Nakashima Masanao   Ohmori Tohru   Adachi Mitsuru  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 267-274

Springer Publishing Company

Access to resources Recommend Favorite

Association between brain natriuretic peptide and distant metastases in advanced non-small cell lung cancer patients

By                      

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 253-256

Spandidos Publications

Access to resources Recommend Favorite

Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer

By Chu Huili   Zhong Chen   Xue Guoliang   Liang Xiuju   Wang Jun   Liu Yingxin   Zhao Shiwei   Zhou Qian   Bi Jingwang  

Oncology Reports, Vol. 30, Iss. 5, 2013-11 ,pp. : 2311-2315

Spandidos Publications

Access to resources Recommend Favorite